Maudsley Forum Scandinavia,
an intensive state-of-the-art educational conference

About Maudsley Forum Scandinavia 19-21 September 2022

The University Psychiatric Department of Helsingborg in collaboration with King’s College London and the Lund University Department of Child and Adolescent Psychiatry proudly present:

Maudsley Forum Scandinavia
- an intensive, three-day state-of-the-art educational conference.


World-class speakers, leading experts from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and distinguished Scandinavian clinicians and researchers, with a worldwide reputation for psychiatric research and clinical care, will meet in Helsingborg and present cutting edge advances in clinical and academic psychiatry. The Forum will provide a top-level update on social, psychological and biological aspects of psychiatric disorders, reviewing advances in diagnostics and new methods of treatment.

It consists of a broad spectrum of lectures, in the fields of Adult Psychiatry, Forensic Psychiatry and Child and Adolescent Psychiatry, addressing topics such as psychotic and mood disorders, addiction, pharmacological and psychological treatment interventions, genetics and epigenetics in psychiatry, neuroimaging and neurocognition. 

Lipus has reviewed and approved this course. Full course description is available at www.lipus.se (Lipus number: 20220118).

The meeting will be held in Helsingborg. More information will follow. 

Please note that the lectures will be in English.


The establishment of this first Maudsley Forum Scandinavia is orchestrated by Professor Sir Robin Murray, Professor Allan Young and Associate Professor Jonas Eberhard, from the Institute of Psychiatry, Psychology & Neuroscience, King's College London and Lund University, Sweden.

Our intention is that this conference will become an annual, long-lasting tradition, introducing a Forum for networking, exchange of ideas and cooperation. The conference is primarily intended for psychiatrists - specialists and residents, but also for clinical psychologists, mental health professionals as well as neuroscientists and students.  

REGISTRATION
Registration is open until 20 August. Register via the button at the top of the page.

Fees 
- Registrations  latest July 31st: 6900 SEK
- Registrations between August 1st - August 20th : 7800 SEK.

Lipus has reviewed and approved this course. The complete course description is available at www.lipus.se (Lipus-no: 20200015).

Organizational committee
- Jonas Eberhard, Associate Professor, Lund University
- Tina Hedberg, Resident (ST-läkare) in Psychiatry, Helsingborg
- Spyridon Baltzis, Psychiatrist in Psychiatry Helsingborg
- Viktor Fabri, Resident (ST-läkare) in Psychiatry Helsigborg
- Maria Holst, Head of the University Psychiatric Department of Helsingborg,
- Gisela Larmark, Consultant psychiatrist, Director of Clinical Education
- Anna Sönnberger, Communicator
- Camilla Christensson, Administrative assistant
- Sandra Malmros, Financial officer

For further information, please contact:
Tina Hedberg, project leader
maudsley.forum.scandinavia@skane.se
+46 790 69 94 04
 

Speakers of the Event

Will be continuously updated. Last modified 25 May 2022.

Dag Aarsland is Professor of Old Age Psychiatry at IoPPN, King’s College London. Visiting professor at the Alzheimer's Disease Research Centre at Karolinska Institutet, Sweden and Research Director at Centre for Age-Related Medicine, Stavanger University Hospital, Norway. A psychiatrist who has worked as a senior consultant in geriatric psychiatry for most of his career. Main research interest is the neuropsychiatric aspects of patients with neurodegenerative diseases, in particular translational studies on cognitive decline in Parkinson’s disease and dementia with Lewy bodies.
Dag Aarsland

Professor

Professor Allan Young holds the Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the IoPPN, King’s College London. Research focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders. He has received research grant funding from the UK Medical Research Council, the Stanley Medical Research Institute, the Canadian Institutes for Heath Research, the National Institutes of Health (USA) and numerous other agencies. He has published over 400 publications and a number of books.
Allan Young

Professor

Fiona Gaughran, Director of Research and Development at the South London and Maudsley NHS Foundation Trust in London, Lead Consultant for the National Psychosis Service. Reader in Psychopharmacology and Physical Health at the Institute of Psychiatry, Psychology and Neuroscience. Fellow of the Royal Colleges of Physicians in London, Edinburgh and Dublin and of the Royal College of Psychiatrists. Implementing new, evidence-based approaches to help people who have psychotic illnesses that have been resistant to treatment. Research interests focus on the interface between physical health and severe mental illness and on the management of psychosis.
Daniel Lindqvist is associate professor of psychiatry at Lund University and director of research, education and development at the Office for Psychiatry and Habilitation, Region Skåne. Dr Lindqvist leads the Unit for Biological and Precision Psychiatry at Lund University. By using blood, brain, and feces biomarkers dr Lindqvist’s group want to delineate specific subgroups of depression, and test the antidepressant efficacy of various interventions targeting these specific biological pathways. The goal of this research program is to advance precision psychiatry by tailoring antidepressant treatments.

 
Daniel Lindqvist

Associate Professor

Sir Robin Murray, Professor of Psychiatric Research at the IoPPN. Particular interest is in psychosis and has contributed to the understanding that environmental factors dysregulate striatal dopamine and thus increase the risk of schizophrenia-like psychoses. He is also involved in testing new treatments for psychotic illnesses, and cares for people with psychosis at the SLaM NHS Foundation Trust. Written over 700 articles. Most frequently cited schizophrenia researcher outside the USA. Has supervised 52 PhDs and 40 of his students have become full professors. Elected a Fellow of the Royal Society in 2010 and received a knighthood in 2011.
Sir Robin Murray

Professor

Jonas Eberhard, MD PhD, Associate Professor, Senior lecturer, Consultant psychiatrist, and Head of the Severe Mental Illness research unit at the Dept of Clinical Sciences, Lund University, Psychiatry Skåne, Helsingborg, Sweden. Focusing on Epidemiology and clinical trials in Severe Mental Illness JE has worked in psychiatry for 40 years and been involved in Psychiatric drug development since the early 90ies e.g. as international medical adviser at Lundbeck HQ in Copenhagen. He is the current Scientific secretary of the Swedish Psychiatric Association and programme responsible for the Swedish Psychiatric congress, and national editor for the Nordic Journal of Psychiatry. Jonas is the author of numerous scientific articles and author/editor of several books in the areas of psychosis, cognition, and psychiatric-physical co-morbidity. Jonas did his basic medical training at the Ludwig Maximilian University in Munich, Germany & the Karolinska Institute in Stockholm. He did most of his clinical training and his dissertation at Lund University in Sweden, and subsequent academic training at the Institute of Psychiatry at the Maudsley, King’s College London.
Jonas Eberhard

Associate Professor

Maria Råstam is senior professor at Lund University and at the University of Gothenburg.
 
She went to Medical School at the University of Gothenburg. She has specialised in General psychiatry and in Child and adolescent psychiatry. In 2008 she was appointed Full professor in Child and adolescent psychiatry at Lund University, associated with a post as senior consultant psychiatrist. Since 2016 she is senior professor at the same university.

Her research areas are the eating disorders and the neurodevelopmental disorders, esp. autism and ADHD. She has published over 140 peer-reviewed papers in international journals.
Maria Råstam Bergström

Professor

Anders Håkansson is a aprofessor of addiction medicine at Lund University, and a consultant physician at the gambling disorder unit and at the outpatient facilities for sports psychiatry at Malmö Addiction Center, Sweden. A large part of Anders Håkansson's research focuses on gambling disorder, its comorbidity, psychiatric, social and societal consequences, and on prevention and harm reduction interventions in problem gambling. Likewise, Anders is the responsible researcher of the regional naloxone trial in Region Skåne, aiming to decrease opioid overdose-related mortality in the society, as well as for a number of other research projects in alcohol and drug use disorder, problem gambling and gaming, as well as in other non-substance behavioral addictions. 
Anders Håkansson

Professor

Professor in the History of Medicine & Psychiatry at King’s College London. Edgar Jones is an authority on the psychological effects of modern war and conflict. He has studied both conventional armed forces and terrorism, exploring how individuals cope during periods of intense stress and the impact of traumatic experiences on their wellbeing. More recently he has researched moral injury, an enduring belief of being wronged or having been compelled to act in ways that feel wrong, in servicemen and women. Edgar Jones has also published on risk factors for radicalisation and support of political violence. He has written extensively on shell shock, post-traumatic stress disorder and chronic multi-symptom illness suffered as a result of military service. The author of a number of reports for government and military or mental health charities, his work seeks to shape policy and practice.  
Edgar Jones

Professor

Sebastian Lundström is a licensed psychologist and associate professor of child and adolescent psychiatry who has worked with large-scale epidemiological studies for more than 15 years and conducted several clinical studies. Sebastian also works clinically and investigates younger children with a suspected autism spectrum disorder.
Sebastian Lundström

Associate Professor

Danish psychiatrist and researcher as well as Editor-in-chief of Nordic Journal of Psychiatry. Published numerous papers including research in the theory of excitotoxic mechanisms in ischemic neuronal necrosis, the effect of seizures on the brain and the efficacy of psychotherapy on depression.  Has postgraduate training in internal medicine, surgery, neurology and neurosurgery at university hospitals in Copenhagen (Glostrup and Gentofte). Psychiatric training at the University Hospitals Bispebjerg Hospital and Rigshospitalet.
Martin Balslev Joergensen

Professor

Dr Shubulade (aka Lade) Smith is a Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust and Visiting Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience, Kings College London. After training in general psychiatry at the Maudsley, she undertook a Research Fellowship in antipsychotic side effects, supervised by Professor Sir Robin Murray. She was nominated as “Woman of the Year” and a BMA Pioneer award for innovation in psychiatry for her “one-stop shop” joint physical-mental health clinic. Dr Smith is the Lead for the Acute Forensic Pathway of the South London Partnership and Clinical Director of the Forensic Services at SLaM. She is also Clinical and Strategic Director of the National Collaborating Centre  Mental Health at the Royal College of Psychiatrists, providing medical leadership for the team developing mental health guidelines. She sat on the core working group of the UK Independent Mental Health Act Review, chaired by Professor Sir Simon Wessely. Dr Smith was awarded a CBE in the Queen’s Birthday Honours in June 2019 for services to Forensic Psychiatry. In November 2019 she was awarded Psychiatrist of the Year by the Royal College of Psychiatrists.
Her research includes tackling mental health inequality; physical health in SMI; implementation of Advance decisions to reduce involuntary detention and the short-term management of violent behaviour. Dr Smith is a Trustee of National Mind and an advisor to Rethink. She is also a Trustee of the Bethlem Gallery. Dr Smith enjoys walking along London’s river, reading and Zumba.
 
Shubulade Smith

Professor 

Professor Mataix-Cols is a clinical psychologist specialised in the study and care of patients with obsessive-compulsive and related disorders. He completed his PhD in 1999 (University of Barcelona). In 2000 he was awarded a Marie Curie Fellowship to conduct post-doctoral research at Imperial College London. From 2002, he was appointed lecturer at King’s College London, where he eventually became a full professor in 2012. In parallel, he developed his clinical activity at the Maudsley Hospital. He is now professor of child and adolescent psychiatric science at the Karolinska Institutet, Stockholm, where he runs a program of research aimed at understanding the causes of obsessive-compulsive and related disorders across the lifespan and the development of cost-effective treatments for these conditions.
David Mataix Cols

Professor

Andreia Hazewinkel is a Dutch psychiatrist. She is trained in the Leiden University Medical Hospital and is currently employed by the PsyQ mental health centre and Brijder treatement centre for addiction care in Leiden.
Her main field of interest is ADHD and its comorbidity, especialy sleeping disorders. She is connected tot he PsyQ ADHD knowlegde centre in the Hague and gives lectures and trainings on this subject.
 
Andreia Hazewinkel

Psychiatrist

Åsa Konradsson-Geuken, Associate Professor in Pharmacology, Department of Pharmaceutical Biosciences, Uppsala University & Helsingborg Clinical Science dept 
Åsas research focuses on finding new treatments that could reduce the recurring psychoses, increase the quality of life and longevity of patients with schizophrenia. The purpose of her studies is to use unique techniques to clarify how drugs, drug candidates and new combinations of molecules affect higher cognitive processes in the brain. These studies may increase our understanding of the neurobiology behind schizophrenia and thereby facilitate the development of new effective drugs.
Åsa Konradsson-Geuken

Associate Professor in Pharmacology 

Sukhi Shergill is Professor of Psychiatry at KMMS and Consultant Psychiatrist and Director of Research at the Kent wide NHS trust (KMPT) since October 2021. He is also Professor of Psychiatry and Systems Neuroscience at the Institute of Psychiatry, Psychology and Neuroscience, King's College London (KCL). He trained in medicine at University College London (UCL), completing a BSc in Psychology before starting his psychiatry training at UCL and completing his higher training at the Maudsley Hospital London. He obtained his PhD at the Institute of Psychiatry KCL and was the recipient of several research fellowships before promotion to Professor in 2014. He heads the Cognition, Schizophrenia and Imaging Laboratory, comprising two-dozen academics, clinical researchers, PhD and other students. He was the founding director of the King’s centre for innovative therapies developing novel therapeutic approaches to mental health between industry and academics/clinicians within KCL. He led the MSc programmes in Mental Health Studies and Organisational Psychiatry and Psychology at KCL for a decade. He has been the recipient of several research and teaching awards; has had extensive grant funding from a range of governmental and charitable sources; published over 250 peer reviewed research publications and supervised more than 20 PhD students.
Sukhi Shergill

Professor

Stephen Bazire is Honorary Professor at the School of Pharmacy, University of East Anglia in Norwich, and a Director of Mistura Enterprise (running the Choice and Medication®) and Mistura Informatics (MaPPs 2®). He was Chief Pharmacist for Norfolk mental health services (1986-2011) and then Consultant Pharmacist in Medicines Management until retiring from the NHS in 2015. He is a Fellow of the Royal Pharmaceutical Society of Great Britain and the College of Mental Health Pharmacy, and was awarded an MBE in 2010 for services to pharmacy and the Guild of Healthcare Pharmacists Gold Medal in 2013. He is a member of David Nutt’s DrugScience Scientific Committee. He is probably best known as the author of the "Psychotropic Drug Directory" (29 editions to 2021 and over half a million copies sold worldwide) and for running the Choice and Medication website. His special clinical interests include depression, bipolar, adult ADHD, and user and carer information and education on medicines. 
Steve Bazire

Professor

Dr Amir Englund has a PhD in Cannabinoid Psychopharamcology from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Over the last decade he has conduced several experimental psychopharmacology studies using cannabinoid in healthy volunteers as well as clinical trials with CBD as a treatment for psychosis.
Amir Englund

Dr 

Robert Kelly is a psychiatrist affiliated with Cornell University and Lund University, working clinically for New York-Presbyterian Hospital in the United States. He serves as associate editor for Nordic Journal of Psychiatry, Psychiatric Diseases section editor for Brain Sciences, and on committees for the American Psychiatric Association. He conducts research in metascience, neuroimaging methods, geriatric psychiatry, and mood disorders. His most recent work focuses on understanding and addressing the so-called “replication crisis”.
Robert Kelly

Docent

Tina Hedberg

Resident (ST-läkare) in Psychiatry, Helsingborg
Project leader Maudsley Forum Scandinavia

Spyridon Baltzis was born in Athens and studied medicine at the University of Crete. He is a specialist in psychiatry and a doctoral student at Lund University. He is the initial project manager of Maudsley Forum Scandinavia that was arranged and cancelled -twice!- due to COVID-19.
Spyridon Baltzis

Psychiatrist

Event Schedule - 19 September

Preliminary programme, subject to changes.

Morning 19 September
  • 9:00 - 9:45 am - Introduction 
  • 9:45 - 10:30 am - Professor Sir Robin Murray

    The growing impact of cannabis on the nature and frequency of psychosis

    Moderator: Jonas Eberhard

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Professor Allan Young

    Psychopharmacological treatment in depression

    Moderator: Tina Hedberg

  • 11:45 - 12:30 am -  Psychiatrist Andreia Hazewinkel

    Sleeping disorders in ADHD

    Moderator: Peik Gustafsson/Pia Tallberg

Afternoon 19 September
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm -  Professor Fiona Gaughran

    The physical health of people with psychosis

  • 2:15-2:45 pm - Fika Pause
  • 2:45-3:30 pm - Professor Dag Aarsland

    Depression and dementia: A fascinating relationship and opportunity for prevention?

    Moderator: Maurits Johansson

  • 3:30-4:15 Professor Sir Robin Murray

    Types of Resistant schizophrenia and their Treatment

    Moderator: Jonas Eberhard

Evening 19 September

Event Schedule - 20 September

Preliminary programme, subject to changes.

Morning 20 September
  • 9:00 - 9:45 am - Dr Amir Englund

    Can we make cannabis safer?

    Moderator: Joakim Ekstrand

  • 9:45 - 10:30 am - Professor Martin Balslev

    ECT

    Moderator: Viktor Fabri/Marcus Persson

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Professor Anders Håkansson

    Gambling disorders - advances in public health and in clinical addiction treatment

    Moderator: Viktor Fabri

  • 11:45 - 12:30 am - Professor Maria Råstam

    Eating disorders in young adults: prevalence, diagnostics and treatment

Afternoon 20 September
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm -  Associate Professor Sebastian Lundström

    Why do so many people get an autism diagnosis?

    Moderator: Johan Nyrenius

  • 2:45 - 3:30 pm - Professor David Mataix Cols

    OCD and related disorders: An update

    Moderator: Peik Gustafsson

  • 3:30 - 4:15 pm - Professor Edgar Jones

    Post-traumatic illness at time of war and pandemic

    Moderator: August Ibsen Snorrasson

Evening 20 September
  • 6:30 - 11:00 pm - Dinner

Event Schedule - 21 September

Preliminary programme, subject to changes.

Morning 21 September
  • 9:00 - 9:45 am - Professor Shubulade Smith

    Violence: neurobiology and management

    Moderator: Björn Hofvander

  • 9:45 - 10:30 am - Associate Professor Daniel Lindqvist

    Precision Psychiatry

    Moderator: Allan Young

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Professor Steve Bazire

    Sex and drugs & rock´n roll

    Moderator: Emma Brogård

  • 11:45 - 12:30 am - Associate Professor Åsa Konradsson-Geuken
     

    New treatment strategies to enhance the efficacy of antipsychotic drugs

    Moderator: Robin Murray

Afternoon 21 September
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm -  Professor Sukhi Shergill

    Understanding neural networks in treatment resistance

    Moderator: Robert Kelly

  • 2:45 - 3:30 pm - Professor Allan Young

    Cognition in mood disorders

    Moderator: Merve Cingi Yirün/Matilda Naessröm 

  • 3:30 - 4:15 pm - Ass. Professor Jonas Eberhard; Robert Kelly and panel

    Progress, Problems , Prospects and Expectations

Evening 21 September

Partners/Sponsors

Venue

Elite Hotel Marina Plaza Helsingborg, Sweden

Event Location

Get Directions

Enjoy your stay in Helsingborg

- Digital guide Helsingborg
- Shopping

Where to stay
The conference is held at Elite hotel Marina Plaza, if you whish to book a room please visit: Hotell Helsingborg - Elite Hotel Marina Plaza | Elite Hotell 

How to get to, and get around in, Helsingborg
- Visit Helsingborg

Public transport
- skanetrafiken.se 

Let's Get Social

Region Skåne Koncernkontoret © . All Rights Reserved.
Landing Page Template Designed & Developed By: Saptarang